Zobrazeno 1 - 10
of 28
pro vyhledávání: '"Kevin Laliberte"'
Autor:
Franz Rischard, Kevin Laliberte, Jeremy Feldman, Murali M. Chakinala, Meredith Broderick, Nicole Leedom, R. James White, Michael A. Mathier
Publikováno v:
The Journal of Heart and Lung Transplantation. 36:193-201
BackgroundParenteral prostanoids are effective treatment for pulmonary arterial hypertension, but long-term pump infusion systems have significant delivery-related safety and convenience limitations.MethodsSubjects with a favorable risk profile trans
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::b0980ea441c7a29bab94f58147ef463c
https://doi.org/10.1016/j.healun.2016.06.019
https://doi.org/10.1016/j.healun.2016.06.019
Autor:
Stanford L. Peng, Kristan D. Rollins, Robert Spiera, Robert W. Simms, Dinesh Khanna, John Varga, Virginia D. Steen, Maureen D. Mayes, Fredrick M. Wigley, Naomi F. Rothfield, Barri J. Fessler, Bashar Kahaleh, Lorinda Chung, Richard M. Silver, David H. Collier, Elena Schiopu, Robyn T. Domsic, Soumya Chatterjee, Michael Wade, Christopher P. Denton, Murray Baron, Kevin Laliberte, Jerry A. Molitor, Mary Ellen Csuka, Vivien Hsu, Thomas A. Medsger, James R. Seibold, Ariane L. Herrick, Tracy M. Frech, Janet E. Pop
Publikováno v:
Journal of Scleroderma and Related Disorders. 2:42-49
Background Prostacyclins are routinely used to treat vascular features of systemic sclerosis (SSc, scleroderma) but require parenteral infusion or inhalation. This study evaluated the safety and efficacy of oral treprostinil in digital ulcers seconda
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::5f329b590b00a7e62256e454c6e4260a
https://doi.org/10.5301/jsrd.5000232
https://doi.org/10.5301/jsrd.5000232
Publikováno v:
Journal of Cardiovascular Pharmacology. 63:227-232
Background Treprostinil diolamine (oral treprostinil) is an orally available prostacyclin analog that was developed for the treatment of pulmonary arterial hypertension. This study aimed to evaluate the pharmacokinetics (PK), safety, and tolerability
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::3e56a38020f5d086b0cf6c70deeec3c4
https://doi.org/10.1097/fjc.0000000000000039
https://doi.org/10.1097/fjc.0000000000000039
Autor:
Victor F. Tapson, Zhi-Cheng Jing, Kai-Feng Xu, Lei Pan, Jeremy Feldman, David G. Kiely, Eugene Kotlyar, C. Shane McSwain, Kevin Laliberte, Carl Arneson, Lewis J. Rubin
Publikováno v:
Chest. 144:952-958
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::4653288186fafb239c1114c2bf05f79a
https://doi.org/10.1378/chest.12-2875
https://doi.org/10.1378/chest.12-2875
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 38:518-523
Summary What is known and objective Treprostinil diolamine (oral treprostinil) is a prostacyclin analogue under evaluation for the treatment for pulmonary arterial hypertension (PAH). This study assessed the pharmacokinetics (PK) and safety of trepro
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::1ece14cf00d2c717d64eb3b9bc8a1de6
https://doi.org/10.1111/jcpt.12094
https://doi.org/10.1111/jcpt.12094
Publikováno v:
Journal of Clinical Pharmacy and Therapeutics. 38:450-455
Summary What is known Treprostinil diolamine (oral treprostinil) is a prostacyclin analogue currently being evaluated for the treatment of pulmonary arterial hypertension as a sustained-release (SR) oral tablet. Previous data have demonstrated that t
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::347c141b4c09c522e53e887efacb8423
https://doi.org/10.1111/jcpt.12085
https://doi.org/10.1111/jcpt.12085
Autor:
Jean Francois Marier, Victor F. Tapson, Kevin Laliberte, Carlos Jerjes, Tomás Pulido, David Yehle, Fernando Torres, Meredith Howell, R. James White, Roblee P Allen
Publikováno v:
Journal of Cardiovascular Pharmacology. 61:474-481
Pulmonary arterial hypertension (PAH) is a progressive vascular disease that ultimately leads to right ventricular failure and death. Treprostinil diolamine is an oral prostacyclin analogue; sustained release tablets of oral treprostinil are currentl
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::259bfdacb6664c60c060e90deaf709b4
https://doi.org/10.1097/fjc.0b013e31828685da
https://doi.org/10.1097/fjc.0b013e31828685da
Publikováno v:
Journal of Cardiovascular Pharmacology. 61:444-451
Treprostinil, a stable prostacyclin analogue used in the treatment of pulmonary arterial hypertension, is in development as a sustained release oral tablet, treprostinil diolamine (United Therapeutics Corp, Research Triangle Park, NC). As combination
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::7b5e65f2a52a2047f5d38cb0d9a255bc
https://doi.org/10.1097/fjc.0b013e3182893d90
https://doi.org/10.1097/fjc.0b013e3182893d90
Autor:
Shelley M. Shapiro, Victor F. Tapson, Kevin Laliberte, Roblee P Allen, Robert P. Frantz, Anne Keogh, Carl Arneson, Fernando Torres, Jeffrey Sigman, David B. Badesch, Adaani E. Frost, Fiona Kermeen, Nazzareno Galiè
Publikováno v:
Chest. 142:1383-1390
Background Treprostinil is a stable prostacyclin analog approved for the treatment of pulmonary arterial hypertension (PAH) as parenteral or inhaled therapy. Treprostinil diolamine, a sustained-release oral formulation of treprostinil, was studied to
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_________::269efa53af0b61fa4a502b081446825b
https://doi.org/10.1378/chest.11-2212
https://doi.org/10.1378/chest.11-2212
Publikováno v:
The Journal of Vascular Access. 6:177-181
Purpose Two animal studies were conducted to determine the feasibility of infusing treprostinil via a central venous catheter at an infusion rate of 0.1 mL/hour. Currently treprostinil is administered intravenously at infusion rates of approximately
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f1d0da8a8198f9080df4fc405e6f80b5
https://doi.org/10.1177/112972980500600404
https://doi.org/10.1177/112972980500600404